anti-inflammatory agents, non-steroidal

Preferred Label : anti-inflammatory agents, non-steroidal;

MeSH definition : Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions.They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.; Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.;

MeSH synonym : non-steroidal anti-inflammatory agents; nonsteroidal anti-inflammatory agents; nsaids; nonsteroidal anti inflammatory agents; anti inflammatory agents, nonsteroidal; antiinflammatory agents, nonsteroidal; nonsteroidal antiinflammatory agents; antiinflammatory agents, non steroidal; non steroidal anti inflammatory agents; NSAID; Nonsteroidal Anti-Inflammatory Agent; Agent, Nonsteroidal Anti-Inflammatory; Anti-Inflammatory Agent, Nonsteroidal; Nonsteroidal Anti Inflammatory Agent; Non-Steroidal Anti-Inflammatory Agent; Agent, Non-Steroidal Anti-Inflammatory; Anti-Inflammatory Agent, Non-Steroidal; Non Steroidal Anti Inflammatory Agent;

CISMeF synonym : anti inflammatory agents, non steroidal; agents, Non-Steroidal Anti-Rheumatic; anti rheumatic agents, non steroidal; Non-Steroidal Anti-Rheumatic agents; antirheumatic agents, Non-Steroidal; agents, Non-Steroidal antirheumatic; antirheumatic agents, non steroidal; Non-Steroidal antirheumatic agents; agents, Aspirin-Like; analgesics, anti inflammatory; anti-inflammatory agents, nonsteroidal; agents, non-steroidal anti-inflammatory; agents, nonsteroidal antiinflammatory; agents, nonsteroidal anti-inflammatory;

MeSH hyponym : Aspirin-Like agents; analgesics, Anti-Inflammatory; Anti-Inflammatory Analgesics; Aspirin Like Agents; Aspirin-Like Agent; Agent, Aspirin-Like; Aspirin Like Agent;

Related MeSH term : Anti-Rheumatic agents, Non-Steroidal;

MeSH annotation : GEN or unspecified: prefer specifics; DF: NSAID;

Wikipedia link : https://en.wikipedia.org/wiki/Nsaid;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D000894;

UMLS CUI

C0003211;

ATC code(s)
- antiinflammatory agents, non-steroids [ATC Code]
- antiinflammatory agents, non-steroids and antiinfectives in combination [ATC Code]
- antiinflammatory and antirheumatic products, non-steroids [ATC Code]
- antiinflammatory preparations, non-steroids for topical use [ATC Code]
- diclofenac [ATC Code]
- diclofenac, combinations [ATC Code]
- floctafenine [ATC Code]
- guacetisal [ATC Code]
- imidazole salicylate [ATC Code]
- indometacin [ATC Code]
- indometacin, combinations [ATC Code]
- other antiinflammatory and antirheumatic agents, non-steroids [ATC Code]
- propionic acid derivatives [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Analgesic anti-inflammatory [ICHI extension code]
- Cellulitis of trunk [ICD-10 Sub-category (who)]
- Connective and soft tissue of pelvis [ICD-10 Sub-category (who)]
- Contusion of abdominal wall [ICD-10 Sub-category (who)]
- Cutaneous abscess, furuncle and carbuncle of trunk [ICD-10 Sub-category (who)]
- Groin [LOINC System]
- Inguinal Region [NCIt concept]
- Inguinal part of abdomen [FMA entity]
- Intentional self-harm by exposure to or harmful effects of other nonsteroidal anti-inflammatory drugs [ICD-11 More detail]
- OLD_CHILD [NCIt concept]
- Open wound of abdominal wall [ICD-10 Sub-category (who)]
- Pelvis [ICD-10 Sub-category (who)]
- Place in family order: oldest sibling (finding) [SNOMED CT concept]
- antiinflammatory agents, non-steroids [ATC Code]
- inguinal region, nos [SNOMED Notion]
- oldest child [SNOMED Notion]
CISMeF manual mappings
- Non-steroidal anti-inflammatory agent (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Anti-inflammatory drug nonsteroidal [ICHI extension code]
- Anti-inflammatory drug nonsteroidal [ICD-11 Extension code]
- Nonsteroidal Antiinflammatory Drug [NCIt concept]
- Nonsteroidal antiinflammatory drugs [LOINC component]
- non-steroidal anti-inflammatory agent, nos [SNOMED Notion]
Indexing information
- (2E,5E)-2,5-bis(4-(3-(dimethylamino)propoxy)benzylidene)cyclopentanone [MeSH Supplementary Concept]
- (E)-4-(3,7-dimethylocta-2,6-dienylamino)phenol [MeSH Supplementary Concept]
- 1,3-dicyclopentyl-1,2,3,6-tetrahydropyrimidine-4,5-dicarboxylic acid diethyl ester [MeSH Supplementary Concept]
- 1,5-diphenyl-1H-pyrazole-3-carbohydrazide [MeSH Supplementary Concept]
- 1-(2-(2-nitrovinyl)phenyl)pyrrolidine [MeSH Supplementary Concept]
- 1-(4-ethoxyphenyl)-3-(4-nitrophenyl)-prop-2-en-1-one [MeSH Supplementary Concept]
- 1-O-octadecyl-2-O-(2-inositolylethyl)-glycero-3-phosphatidylcholine [MeSH Supplementary Concept]
- 1-phenyl-3-(thiophen-2-yl)prop-2-en-1-one [MeSH Supplementary Concept]
- 14-(ethylamino)-8,9,16-trihydroxy-3,4-dimethyl-3,4,9,19-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione [MeSH Supplementary Concept]
- 17,18-dihydroxyeicosapentaenoic acid [MeSH Supplementary Concept]
- 2''-cysteinyl-epigallocatechin-3-gallate [MeSH Supplementary Concept]
- 2'-cysteinyl-epigallocatechin-3-gallate [MeSH Supplementary Concept]
- 2,4-dihydroxy-N-(4-hydroxyphenyl)benzamide [MeSH Supplementary Concept]
- 2-(2-hydroxy-4-methoxyphenyl)-5-(3-hydroxypropyl)benzofuran [MeSH Supplementary Concept]
- 2alpha-acetoxy-4alpha,6alpha-dihydroxy-1beta,5alphaH-guai-9(10),11(13)-dien-12,8alpha-olide [MeSH Supplementary Concept]
- 3'-demethyldeoxymethymycin [MeSH Supplementary Concept]
- 3'-demethylmethymycin [MeSH Supplementary Concept]
- 3,4-dimethoxycinnamyl 9-O-beta-D-glucopyranoside [MeSH Supplementary Concept]
- 3,4-dimethoxyphenylglucosinolate [MeSH Supplementary Concept]
- 3-(4H-1,2,4-triazol-3-ylthio)-N-phenylpropanamide [MeSH Supplementary Concept]
- 3-O-(2'-acetoxy)benzoyl-2-glucopyranose [MeSH Supplementary Concept]
- 4,2',5'-trihydroxy-4'-methoxychalcone [MeSH Supplementary Concept]
- 4-(2-(aminomethyl)-3-fluoroallyloxy)benzenesulfonamide [MeSH Supplementary Concept]
- 4-(3-((3-hydroxy-2-(oct-2-enyl)-5-oxocyclopentylidene)methyl)oxiran-2-yl)butanoic acid [MeSH Supplementary Concept]
- 4-(4-methoxyphenoxy)naphthalene-1,2-dione [MeSH Supplementary Concept]
- 4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide [MeSH Supplementary Concept]
- 4-acetyl-3-methyl-6-(2-bromophenyl)pyrano(3,4-c)pyran-1,8-dione [MeSH Supplementary Concept]
- 4-aminophenylbenzoxazol-2-yl-5-acetic acid [MeSH Supplementary Concept]
- 4beta,10alpha-dihydroxy-5alphaH-guai-1(2),11(13)-dien-12,8alpha-olide [MeSH Supplementary Concept]
- 5-(4-(benzoxazol-2-yl-5-acetic acid)phenylazo)-2-hydroxybenzoic acid [MeSH Supplementary Concept]
- 7-methylaromadendrin [MeSH Supplementary Concept]
- 8-(3,4-dihydroxyphenyl)-9,10-dihydro-5,9-dihydroxy-2H,8H-pyrano(2,3-f)chromen-2-one [MeSH Supplementary Concept]
- 8-hydroxy-3-oxopimar-15-ene [MeSH Supplementary Concept]
- 8-methoxylapachenol [MeSH Supplementary Concept]
- 9-dehydro-17-hydro-andrographolide-19-yl sulfuric acid [MeSH Supplementary Concept]
- AAD-2004 [MeSH Supplementary Concept]
- ABD455 [MeSH Supplementary Concept]
- Andrographis paniculata extract [MeSH Supplementary Concept]
- CD-101 [MeSH Supplementary Concept]
- CDSO3 compound [MeSH Supplementary Concept]
- F1 CX3CR1 ligand peptide [MeSH Supplementary Concept]
- KYKZL-1 compound [MeSH Supplementary Concept]
- Leflunomide [MeSH Descriptor]
- Limonene [MeSH Descriptor]
- N-(3-(1-(10-methoxy-6H-benzo(c)(1)benzoxepin-11-ylidene)propyl)phenyl)methanesulfonamide [MeSH Supplementary Concept]
- N-(3-fluorophenyl)ethylcaffeamide [MeSH Supplementary Concept]
- N-(4-methylcyclohexyl)-1-benzyl-1,8-naphthyridin-2(1H)-on-3-carboxamide [MeSH Supplementary Concept]
- N-(8-cyano-1,2,3,4,10,14b-hexahydro-10-methyl dibenzo(c,f)pyrido(1,2-a)azepin-2-yl)-4-methyl-1,2,3-thiadiazole-5-carboxamide [MeSH Supplementary Concept]
- N-(pyridine-3-ylmethyl)-5-(7-hydroxy-2,6,8-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-yl)-2-methylpenta-2,4-dienamide [MeSH Supplementary Concept]
- N-benzylcinnamide [MeSH Supplementary Concept]
- N-cycloheptyl-1-(2-morpholin-4-ylethyl)quinolin-2(1H)-on-3-carboxamide [MeSH Supplementary Concept]
- N-cycloheptyl-1-(p-fluorobenzyl)-1,2-dihydro-2-oxopyridine-3-carboxamide [MeSH Supplementary Concept]
- N1-p-fluorobenzylcymserine [MeSH Supplementary Concept]
- Ph8 peptide [MeSH Supplementary Concept]
- URMC-099 [MeSH Supplementary Concept]
- afzelechin 5-O-beta-D-glucopyranoside [MeSH Supplementary Concept]
- arcommunol D [MeSH Supplementary Concept]
- arcommunol E [MeSH Supplementary Concept]
- azelastine [MeSH Supplementary Concept]
- bis-N-norgliovictin [MeSH Supplementary Concept]
- bullatine A [MeSH Supplementary Concept]
- caesalpiniaphenol D [MeSH Supplementary Concept]
- cantalasaponin-1 [MeSH Supplementary Concept]
- carapin [MeSH Supplementary Concept]
- cecropin A [MeSH Supplementary Concept]
- cicadamide A [MeSH Supplementary Concept]
- cicadamide B [MeSH Supplementary Concept]
- dehydrogeijerin [MeSH Supplementary Concept]
- duvelisib [MeSH Supplementary Concept]
- emodin-6-O-glucoside [MeSH Supplementary Concept]
- ethyl salicylate 2-O-glucoside [MeSH Supplementary Concept]
- ethyl tumonoate A [MeSH Supplementary Concept]
- eunicidiol [MeSH Supplementary Concept]
- flexibilisquinone [MeSH Supplementary Concept]
- floderm topical cream [MeSH Supplementary Concept]
- flunixin [MeSH Supplementary Concept]
- flunixin meglumine [MeSH Supplementary Concept]
- flurbiprofen benzyl nitrate [MeSH Supplementary Concept]
- glaucocalyxin A [MeSH Supplementary Concept]
- glaucocalyxin B [MeSH Supplementary Concept]
- hesperetin-7-O-glucuronide [MeSH Supplementary Concept]
- inflexanin B [MeSH Supplementary Concept]
- inophinnin [MeSH Supplementary Concept]
- isorhamnetin-3-O-galactoside [MeSH Supplementary Concept]
- jeevaneeya rasayana [MeSH Supplementary Concept]
- konishone [MeSH Supplementary Concept]
- lenidase [MeSH Supplementary Concept]
- lobolide [MeSH Supplementary Concept]
- magnoline [MeSH Supplementary Concept]
- melodamide A [MeSH Supplementary Concept]
- myrtacine [MeSH Supplementary Concept]
- naftifine [MeSH Supplementary Concept]
- negundoin A [MeSH Supplementary Concept]
- ophiopogonanone H [MeSH Supplementary Concept]
- prim-O-glucosylcimifugin [MeSH Supplementary Concept]
- prostratol [MeSH Supplementary Concept]
- pulchellamin G [MeSH Supplementary Concept]
- resolvin D3 [MeSH Supplementary Concept]
- rose-oxide [MeSH Supplementary Concept]
- sacran [MeSH Supplementary Concept]
- tectroside [MeSH Supplementary Concept]
- tetramethylpyrazine [MeSH Supplementary Concept]
- trans-4-(1-((2,5-dichloro-4-(1-methyl-3-indolylcarboxyamide)phenyl)acetyl)-(4S)-methoxy-(2S)-pyrrolidinylmethoxy)cyclohexanecarboxylic acid [MeSH Supplementary Concept]
- triptolide [MeSH Supplementary Concept]
Record concept(s)
- Anti-Inflammatory agents, Non-Steroidal [MeSH concept]
- Aspirin-Like agents [MeSH concept]
- analgesics, Anti-Inflammatory [MeSH concept]
See also
- cyclooxygenase inhibitors [MeSH Descriptor]
- fever [MeSH Descriptor]
See also (suggested by CISMeF)
- antipyretics [MeSH Descriptor]
- asthma, Aspirin-Induced [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid [MeSH Supplementary Concept]
- 2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine [MeSH Supplementary Concept]
- 2-aminomethyl-4-t-butyl-6-iodophenol [MeSH Supplementary Concept]
- 2-diethylaminoethanol [MeSH Supplementary Concept]
- 4-bromo-2,7-dimethoxy-3H-phenothiazin-3-one [MeSH Supplementary Concept]
- 6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole [MeSH Supplementary Concept]
- 6-acetylaminocaproic acid [MeSH Supplementary Concept]
- Adapalene [MeSH Descriptor]
- Adapalene, Benzoyl Peroxide Drug Combination [MeSH Descriptor]
- Arteparon [MeSH Supplementary Concept]
- Arthrotec [MeSH Supplementary Concept]
- BI 607812 BS [MeSH Supplementary Concept]
- CDP 571 [MeSH Supplementary Concept]
- CP 96345 [MeSH Supplementary Concept]
- CX 659S [MeSH Supplementary Concept]
- Etanercept [MeSH Descriptor]
- FR 167653 [MeSH Supplementary Concept]
- FR 173657 [MeSH Supplementary Concept]
- IH 764-3 [MeSH Supplementary Concept]
- N-(9H-(2,7-dimethylfluoren-9-ylmethoxy)carbonyl)leucine [MeSH Supplementary Concept]
- NAAA inhibitor F215 [MeSH Supplementary Concept]
- Nebacetin [MeSH Supplementary Concept]
- Olopatadine Hydrochloride [MeSH Descriptor]
- RNS60 [MeSH Supplementary Concept]
- Resveratrol [MeSH Descriptor]
- Rumalon [MeSH Supplementary Concept]
- SB 203580 [MeSH Supplementary Concept]
- SC 41930 [MeSH Supplementary Concept]
- SK&F 105685 [MeSH Supplementary Concept]
- ST 679 [MeSH Supplementary Concept]
- Sul-121 [MeSH Supplementary Concept]
- aceclofenac [MeSH Supplementary Concept]
- acemetacin [MeSH Supplementary Concept]
- acetaminophen, aspirin, caffeine drug combination [MeSH Supplementary Concept]
- acetaminophen, butalbital, caffeine drug combination [MeSH Supplementary Concept]
- acetaminophen, hydrocodone drug combination [MeSH Supplementary Concept]
- acetosyringone [MeSH Supplementary Concept]
- acetovanillone [MeSH Supplementary Concept]
- alclofenac [MeSH Supplementary Concept]
- alminoprofen [MeSH Supplementary Concept]
- alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol [MeSH Supplementary Concept]
- amiprilose [MeSH Supplementary Concept]
- ampyrone [MeSH Descriptor]
- amylase, phosphates, proteases drug combinations [MeSH Supplementary Concept]
- andrographolide [MeSH Supplementary Concept]
- anisodamine [MeSH Supplementary Concept]
- anisodine [MeSH Supplementary Concept]
- antiflammin P2 [MeSH Supplementary Concept]
- antipyrine [MeSH Descriptor]
- apazone [MeSH Descriptor]
- apremilast [MeSH Supplementary Concept]
- aspirin, aluminum hydroxide, magnesium hydroxide drug combination [MeSH Supplementary Concept]
- aspirin, butalbital and caffeine drug combination [MeSH Supplementary Concept]
- aspirin, meprobamate drug combination [MeSH Supplementary Concept]
- atrinositol [MeSH Supplementary Concept]
- azulene [MeSH Supplementary Concept]
- baicalin [MeSH Supplementary Concept]
- balsalazide [MeSH Supplementary Concept]
- bendazac [MeSH Supplementary Concept]
- bendazac lysine [MeSH Supplementary Concept]
- benorilate [MeSH Supplementary Concept]
- benoxaprofen [MeSH Supplementary Concept]
- benzobarbital [MeSH Supplementary Concept]
- berbamine [MeSH Supplementary Concept]
- bevonium [MeSH Supplementary Concept]
- biphenylylacetic acid [MeSH Supplementary Concept]
- boldine [MeSH Supplementary Concept]
- boswellic acid [MeSH Supplementary Concept]
- bromfenac [MeSH Supplementary Concept]
- bucillamine [MeSH Supplementary Concept]
- bufexamac [MeSH Descriptor]
- bumadizone [MeSH Supplementary Concept]
- butibufen [MeSH Supplementary Concept]
- carbaspirin calcium [MeSH Supplementary Concept]
- carprofen [MeSH Supplementary Concept]
- caryophyllene [MeSH Supplementary Concept]
- castanospermine [MeSH Supplementary Concept]
- cepharanthine [MeSH Supplementary Concept]
- chloroquine diphosphate [MeSH Supplementary Concept]
- choline magnesium trisalicylate [MeSH Supplementary Concept]
- chrysarobin [MeSH Supplementary Concept]
- clonixin [MeSH Descriptor]
- curcumin [MeSH Descriptor]
- dan-shen root extract [MeSH Supplementary Concept]
- dauricine [MeSH Supplementary Concept]
- dexketoprofen trometamol [MeSH Supplementary Concept]
- diclofenac hydroxyethylpyrrolidine [MeSH Supplementary Concept]
- difenpiramide [MeSH Supplementary Concept]
- dimephosphon [MeSH Supplementary Concept]
- dipyrone [MeSH Descriptor]
- diucifon [MeSH Supplementary Concept]
- droxicam [MeSH Supplementary Concept]
- ecallantide [MeSH Supplementary Concept]
- eltenac [MeSH Supplementary Concept]
- enfenamic acid [MeSH Supplementary Concept]
- enkephalin-Leu, Ala(2)-Arg(6)- [MeSH Supplementary Concept]
- epirizole [MeSH Descriptor]
- ethenzamide [MeSH Supplementary Concept]
- etofenamate [MeSH Supplementary Concept]
- evening primrose oil [MeSH Supplementary Concept]
- fenamic acid [MeSH Supplementary Concept]
- fenclofenac [MeSH Supplementary Concept]
- fenflumizole [MeSH Supplementary Concept]
- fentiazac [MeSH Supplementary Concept]
- fepradinol [MeSH Supplementary Concept]
- feprazone [MeSH Descriptor]
- ferulic acid [MeSH Supplementary Concept]
- floctafenine [MeSH Supplementary Concept]
- flunixin [MeSH Supplementary Concept]
- flunixin meglumine [MeSH Supplementary Concept]
- flunoxaprofen [MeSH Supplementary Concept]
- fluproquazone [MeSH Supplementary Concept]
- flurbiprofen axetil [MeSH Supplementary Concept]
- glucametacin [MeSH Supplementary Concept]
- guacetisal [MeSH Supplementary Concept]
- helenalin [MeSH Supplementary Concept]
- heliodermin [MeSH Supplementary Concept]
- hemodes [MeSH Supplementary Concept]
- higenamine [MeSH Supplementary Concept]
- ibuproxam [MeSH Supplementary Concept]
- icatibant [MeSH Supplementary Concept]
- imidazole-2-hydroxybenzoate [MeSH Supplementary Concept]
- iodoantipyrine [MeSH Supplementary Concept]
- isoxicam [MeSH Supplementary Concept]
- kebuzone [MeSH Supplementary Concept]
- ketoprofen lysine [MeSH Supplementary Concept]
- lipoxin A4 [MeSH Supplementary Concept]
- lipoxin B4 [MeSH Supplementary Concept]
- lisofylline [MeSH Supplementary Concept]
- lobenzarit [MeSH Supplementary Concept]
- lonazolac [MeSH Supplementary Concept]
- lornoxicam [MeSH Supplementary Concept]
- loxoprofen [MeSH Supplementary Concept]
- magnolol [MeSH Supplementary Concept]
- manoalide [MeSH Supplementary Concept]
- mesalamine [MeSH Descriptor]
- mirikizumab [MeSH Supplementary Concept]
- mizoribine [MeSH Supplementary Concept]
- mofebutazone [MeSH Supplementary Concept]
- muricarpone B [MeSH Supplementary Concept]
- nafamostat [MeSH Supplementary Concept]
- nepafenac [MeSH Supplementary Concept]
- nifenazone [MeSH Supplementary Concept]
- nitroaspirin [MeSH Supplementary Concept]
- olsalazine [MeSH Supplementary Concept]
- olvanil [MeSH Supplementary Concept]
- oren gedoku to [MeSH Supplementary Concept]
- orgotein [MeSH Supplementary Concept]
- oxyphenbutazone [MeSH Descriptor]
- palmidrol [MeSH Supplementary Concept]
- parthenolide [MeSH Supplementary Concept]
- peoniflorin [MeSH Supplementary Concept]
- phenylbutazone [MeSH Descriptor]
- pimecrolimus [MeSH Supplementary Concept]
- pirfenidone [MeSH Supplementary Concept]
- piroxicam-beta-cyclodextrin [MeSH Supplementary Concept]
- pirprofen [MeSH Supplementary Concept]
- proglumetacin [MeSH Supplementary Concept]
- propacetamol [MeSH Supplementary Concept]
- propionylcarnitine [MeSH Supplementary Concept]
- propyphenazone [MeSH Supplementary Concept]
- pyranoprofen [MeSH Supplementary Concept]
- pyrazolone [MeSH Supplementary Concept]
- pyrogenal [MeSH Supplementary Concept]
- rosmarinic acid [MeSH Supplementary Concept]
- saiko-keishi-to [MeSH Supplementary Concept]
- saikosaponin D [MeSH Supplementary Concept]
- salicylamide [MeSH Supplementary Concept]
- salicylsalicylic acid [MeSH Supplementary Concept]
- semapimod [MeSH Supplementary Concept]
- seratrodast [MeSH Supplementary Concept]
- serratiopeptidase [MeSH Supplementary Concept]
- shakuyaku-kanzoh-toh [MeSH Supplementary Concept]
- shikonin [MeSH Supplementary Concept]
- sulfasalazine [MeSH Descriptor]
- sulindac sulfide [MeSH Supplementary Concept]
- suxibuzone [MeSH Supplementary Concept]
- tanshinone [MeSH Supplementary Concept]
- taxifolin [MeSH Supplementary Concept]
- tepoxalin [MeSH Supplementary Concept]
- teriflunomide [MeSH Supplementary Concept]
- tiaprofenic acid [MeSH Supplementary Concept]
- tiaramide [MeSH Supplementary Concept]
- tinoridine [MeSH Supplementary Concept]
- tolfenamic acid [MeSH Supplementary Concept]
- tramadol, dexketoprofen drug combination [MeSH Supplementary Concept]
- tranilast [MeSH Supplementary Concept]
- tribenoside [MeSH Supplementary Concept]
- zileuton [MeSH Supplementary Concept]
- zomepirac [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Anti-inflammatory drug nonsteroidal [ICD-11 Extension code]
- Non-steroidal anti-inflammatory agent (product) [SNOMED CT concept]
- Non-steroidal anti-inflammatory agent (substance) [SNOMED CT concept]
- Nonsteroidal Antiinflammatory Drug [NCIt concept]
- Nonsteroidal antiinflammatory drugs [LOINC component]
- non-steroidal anti-inflammatory agent, nos [SNOMED Notion]
Validated automatic mappings to BTNT
- Analgesic anti-inflammatory [ICD-11 Extension code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients